A Disruptive Approach to Alzheimer's & Other Diseases
Learn about usOUR MISSION
To develop a first-in-class approach
for treating Alzheimer’s disease,
comprising diagnostic and therapeutic
strategies, both based on a novel biological
mechanism
Neuro-Bio is a privately owned biotech, with a focus on neurodegenerative diseases. We have discovered a novel molecule – T14 which is toxic in the adult brain and a key driver of neurodegeneration.
We are developing a pre-symptomatic biomarker and drug based on this mechanism.
OUR VALIDATION
Neuro-Bio are proud to announce our paper published May 2024 has received over 4,000 views!
“Evidence for a novel neuronal mechanism driving Alzheimer’s disease, upstream of amyloid”
Our Collaborators
